Select Guide Rating

• Section 1: GeneralClinical pharmacologyTopics in drug therapyDiscovery and development of drugsEvaluation of drugs in humansHealth technology assessment for pharmaceutical productsRegulation of medicinesClassification and naming of drugsPolypharmacy and medicines optimisationSection 2: From pharmacology to toxicologyGeneral pharmacologyUnwanted effects and adverse drug reactionsPoisoning, overdose, antidotesDrug dependenceSection 3: Infection and inflammationChemotherapy of infectionsAntibacterial drugsChemotherapy of bacterial infectionsViral, fungal, protozoal and helminthic infectionsTherapeutics for COVID-19Drugs for inflammation and joint diseaseDrugs and the skinSection 4: Nervous systemPain and analgesicsAnesthesia and neuromuscular blockPsychotropic drugsNeurological disorders - epilepsy, Parkinson’s disease and multiple sclerosisSection 5: Cardiorespiratory and renal systemsCholinergic and antimuscarinic (anticholinergic) mechanisms and drugsAdrenergic mechanisms and drugsCardiovascular disease and heart failureCardiac arrhythmiasHyperlipidaemiasKidney and genitourinary tractRespiratory systemSection 6: Blood and neoplastic diseaseDrugs and haemostasisRed blood cell disordersNeoplastic disease and immunosuppressionSection 7: Gastrointestinal systemOesophagus, stomach and duodenumIntestinesLiver and biliary tractSection 8: Endocrine system, metabolic conditionsAdrenal corticosteroids, antagonists, corticotropinDiabetes mellitus and obesityThyroid hormones, antithyroid drugsHypothalamic, pituitary and sex hormonesVitamins, calcium and bone

Select Guide Rating

• Section 1: GeneralClinical pharmacologyTopics in drug therapyDiscovery and development of drugsEvaluation of drugs in humansHealth technology assessment for pharmaceutical productsRegulation of medicinesClassification and naming of drugsPolypharmacy and medicines optimisationSection 2: From pharmacology to toxicologyGeneral pharmacologyUnwanted effects and adverse drug reactionsPoisoning, overdose, antidotesDrug dependenceSection 3: Infection and inflammationChemotherapy of infectionsAntibacterial drugsChemotherapy of bacterial infectionsViral, fungal, protozoal and helminthic infectionsTherapeutics for COVID-19Drugs for inflammation and joint diseaseDrugs and the skinSection 4: Nervous systemPain and analgesicsAnesthesia and neuromuscular blockPsychotropic drugsNeurological disorders - epilepsy, Parkinson’s disease and multiple sclerosisSection 5: Cardiorespiratory and renal systemsCholinergic and antimuscarinic (anticholinergic) mechanisms and drugsAdrenergic mechanisms and drugsCardiovascular disease and heart failureCardiac arrhythmiasHyperlipidaemiasKidney and genitourinary tractRespiratory systemSection 6: Blood and neoplastic diseaseDrugs and haemostasisRed blood cell disordersNeoplastic disease and immunosuppressionSection 7: Gastrointestinal systemOesophagus, stomach and duodenumIntestinesLiver and biliary tractSection 8: Endocrine system, metabolic conditionsAdrenal corticosteroids, antagonists, corticotropinDiabetes mellitus and obesityThyroid hormones, antithyroid drugsHypothalamic, pituitary and sex hormonesVitamins, calcium and bone

Select Guide Rating

• Section 1: GeneralClinical pharmacologyTopics in drug therapyDiscovery and development of drugsEvaluation of drugs in humansHealth technology assessment for pharmaceutical productsRegulation of medicinesClassification and naming of drugsPolypharmacy and medicines optimisationSection 2: From pharmacology to toxicologyGeneral pharmacologyUnwanted effects and adverse drug reactionsPoisoning, overdose, antidotesDrug dependenceSection 3: Infection and inflammationChemotherapy of infectionsAntibacterial drugsChemotherapy of bacterial infectionsViral, fungal, protozoal and helminthic infectionsTherapeutics for COVID-19Drugs for inflammation and joint diseaseDrugs and the skinSection 4: Nervous systemPain and analgesicsAnesthesia and neuromuscular blockPsychotropic drugsNeurological disorders - epilepsy, Parkinson’s disease and multiple sclerosisSection 5: Cardiorespiratory and renal systemsCholinergic and antimuscarinic (anticholinergic) mechanisms and drugsAdrenergic mechanisms and drugsCardiovascular disease and heart failureCardiac arrhythmiasHyperlipidaemiasKidney and genitourinary tractRespiratory systemSection 6: Blood and neoplastic diseaseDrugs and haemostasisRed blood cell disordersNeoplastic disease and immunosuppressionSection 7: Gastrointestinal systemOesophagus, stomach and duodenumIntestinesLiver and biliary tractSection 8: Endocrine system, metabolic conditionsAdrenal corticosteroids, antagonists, corticotropinDiabetes mellitus and obesityThyroid hormones, antithyroid drugsHypothalamic, pituitary and sex hormonesVitamins, calcium and bone